Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
5.54
-0.31 (-5.30%)
At close: Apr 1, 2025, 4:00 PM
5.56
+0.01 (0.27%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Mind Medicine (MindMed) Employees
Mind Medicine (MindMed) had 74 employees as of December 31, 2024. The number of employees increased by 17 or 29.82% compared to the previous year.
Employees
74
Change (1Y)
17
Growth (1Y)
29.82%
Revenue / Employee
n/a
Profits / Employee
-$1,468,635
Market Cap
417.54M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 74 | 17 | 29.82% |
Dec 31, 2023 | 57 | 9 | 18.75% |
Dec 31, 2022 | 48 | 7 | 17.07% |
Dec 31, 2021 | 41 | 19 | 86.36% |
Dec 31, 2020 | 22 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MNMD News
- 8 days ago - MindMed Announces New Employee Inducement Grants - Business Wire
- 15 days ago - MindMed Appoints Matt Wiley as Chief Commercial Officer - Business Wire
- 26 days ago - Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates - Business Wire
- 4 weeks ago - MindMed to Present at Leerink's Global Healthcare Conference 2025 - Business Wire
- 5 weeks ago - MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Business Wire
- 2 months ago - MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 2 months ago - MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - Business Wire